Conference Reports for NATAP
The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back
 
Up to 12 months' durability of functional cure with bepirovirsen plus Peg-IFN sequential therapy in B-Together responders: B-Sure study
AASLD 2025 Nov 7-11 Wash DC Carla S. Coffin1